STIM1 and lysosomal storage disease: Since protein levels of LAMP2 increase also in lysosomal storage diseases such as neuronal ceroid lipofuscinosis or after treatment with lysosomotropic drugs [29], these results suggest that the endosomal/lysosomal pathway is also affected by Tam.